Mona Lichtblau, MD is an expert in Pulmonology at University Hospital of Zurich (Switzerland). As of October 2026, ScienceLeadR ranks Mona Lichtblau in the top 1% of experts worldwide for Hypoxia, Hypertension and Hypertension, Pulmonary. Mona Lichtblau has authored 253 publications, the most recent in 2026, and is an investigator in 29 clinical trials, 8 of them ongoing. SLR score: 969 (community average: 125). How the SLR is computed.

LeadR Profile

Mona Lichtblau, MD University Hospital of Zurich Switzerland
969 ScienceLeadR Reputation 969
Network Map

Pulmonology

Subspecialties: Cardiology - Public Health

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Organizations

Career arc: 2012 - 2026

Source: PubMed

University Hospital of Zurich

Publications Synthesis

Sources: PubMed, OpenAlex

Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
Effect of low-flow oxygen therapy on 6 minute walk test in pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension: a randomized non-inferiority crossover trial.
PMID 42688806 — exercise, hypertension, hypertension, pulmonary, air, pulmonary arterial hypertension, therapeutics, walk test
Eur Heart J Open20260
The Association Between Chronic High-Altitude Exposure and Increased Pulmonary Vascular Resistance in Healthy High-Altitude Residents: A Systematic Review and Meta-Analysis.
PMID 42609070 — bias, vascular resistance, altitude, hypoxia, records
High Alt Med Biol20260
Nocturnal Cerebral Oxygenation in Low-Altitude Residents With Pulmonary Vascular Disease Staying Overnight at High Altitude. Data From a Randomized, Controlled, Crossover Trial.
PMID 42516695 — air, altitude, vascular diseases
Pulm Circ20260
Iron Homeostasis at High Altitude in Patients With Pulmonary Hypertension.
PMID 42516682 — hypertension, hypertension, pulmonary, transferrin, homeostasis, pulmonary arterial hypertension, altitude, hypoxia
Pulm Circ20260
Angiotensin Converting Enzyme Inhibition and Mortality in Pulmonary Hypertension Associated With Chronic Obstructive Pulmonary Disease (PH-COPD).
PMID 42516688 — hypertension, mortality, hypertension, pulmonary, peptidyl-dipeptidase a, pulmonary disease, chronic obstructive, angiotensins, enzymes, lung diseases, lung diseases, obstructive
Pulm Circ20260

Clinical Studies 29

Sources: ClinicalTrials, EU CTIS

Synthesis

Principal Investigator: 4

By phase:

N/A 18
Phase 4 8
Phase 2/Phase 3 2
Phase 2 1

By status:

Completed 17
Recruiting 9
Active not recruiting 2
Terminated 1

By type:

Interventional 27
Observational 2

By Monocentric/Multicentric:

monocentric 26
multicentric2to4 2
multicentric5to9 1
multicentricup10 0

Main Topics

Ongoing Clinical Trials

8 ongoing trials started since 2021, where this expert is an investigator

Source: ClinicalTrials

Study Phase Status Start
Exercise Performance on Ambient Air vs Low Flow Liquid Oxygen Therapy in Chronic Lung Diseases
NCT07777367 — exercise, hypertension, lung, hypertension, pulmonary, air, pulmonary arterial hypertension, vascular diseases, therapeutics, lung diseases, walk test
N/ARecruiting2026
Exercise Performance on Ambient Air vs Low Flow Liquid Oxygen Therapy in Pulmonary Vascular Disease (PVD)
NCT07777445 — exercise, hypertension, hypertension, pulmonary, air, pulmonary arterial hypertension, vascular diseases, therapeutics, lung diseases, walk test
N/ARecruiting2026
Feasibility of Integrating Street Racket Into Ambulatory Pulmonary Rehabilitation
NCT07430943 — exercise, physical therapists, hypertension, feasibility studies, chronic disease, hypertension, pulmonary, exercise therapy, rehabilitation, motor activity, pulmonary disease, chronic obstructive, therapeutics, lung diseases
N/ARecruiting2026
Effect of Acute Hypoxia on RIght VEntRicular Function in Asthma
NCT07431580 — lung, blood, respiration, heart rate, heart, transcription factors, stress, physiological, altitude sickness, altitude, hypoxia, asthma, dyspnea, ventricular function, tissues, ventricular function, right, re1-silencing transcription factor
N/ARecruiting2026
Effect of Acute Hypoxia on RIght VEntRicular Function in HAPE
NCT07431554 — lung, blood, respiration, heart rate, heart, transcription factors, stress, physiological, altitude sickness, altitude, hypoxia, dyspnea, ventricular function, tissues, ventricular function, right, re1-silencing transcription factor
N/ARecruiting2026

LeadR Networks

Main global connection map